124 related articles for article (PubMed ID: 8842994)
1. Fatal Candida tropicalis fungaemia in a leukaemic patient receiving fluconazole prophylaxis.
Barnes AJ; Wardley AM; Oppenheim BA; Morgenstern GR; Scarffe JH; Warnock DW; Johnson EM
J Infect; 1996 Jul; 33(1):43-5. PubMed ID: 8842994
[TBL] [Abstract][Full Text] [Related]
2. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
Girmenia C; Moleti ML; Micozzi A; Iori AP; Barberi W; Foà R; Martino P
J Clin Microbiol; 2005 Oct; 43(10):5395-6. PubMed ID: 16208029
[TBL] [Abstract][Full Text] [Related]
3. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Krcmery V; Oravcova E; Spanik S; Mrazova-Studena M; Trupl J; Kunova A; Stopkova-Grey K; Kukuckova E; Krupova I; Demitrovicova A; Kralovicova K
J Antimicrob Chemother; 1998 Mar; 41(3):373-80. PubMed ID: 9578164
[TBL] [Abstract][Full Text] [Related]
4. Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: case report and review of the literature.
Weers-Pothoff G; Havermans JF; Kamphuis J; Sinnige HA; Meis JF
Infection; 1997; 25(2):109-11. PubMed ID: 9108187
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study.
Liu WL; Huang YT; Hsieh MH; Hii IM; Lee YL; Ho MW; Liu CE; Chen YH; Wang FD
Int J Antimicrob Agents; 2019 Feb; 53(2):185-189. PubMed ID: 30722962
[TBL] [Abstract][Full Text] [Related]
7. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
8. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
9. Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors.
Leung AY; Chim CS; Ho PL; Cheng VC; Yuen KY; Lie AK; Au WY; Liang R; Kwong YL
J Hosp Infect; 2002 Apr; 50(4):316-9. PubMed ID: 12014908
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole resistance of Candida krusei.
Manso E; Montillo M; Discepoli G; Leoni P
Boll Ist Sieroter Milan; 1991-1992; 70(1-2):527-9. PubMed ID: 1670057
[TBL] [Abstract][Full Text] [Related]
11. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitro.
Krcmery V; Huttova M; Mateicka F; Laho L; Jurga L; Ondrusova A; Tarekova Z; Kralinsky K; Hanzen J; Liskova A; Mrazova M; Sabo A; Pisarcikova M; Kovacicova G; Chovancova D; Szovenyiova Z
J Antimicrob Chemother; 2001 Oct; 48(4):521-5. PubMed ID: 11581231
[TBL] [Abstract][Full Text] [Related]
13. Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit.
Faiz S; Neale B; Rios E; Campos T; Parsley E; Patel B; Ostrosky-Zeichner L
Eur J Clin Microbiol Infect Dis; 2009 Jun; 28(6):689-92. PubMed ID: 19011913
[TBL] [Abstract][Full Text] [Related]
14. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
15. Invasive infection in an acute myeloblastic leukemia patient due to triazole-resistant Candida tropicalis.
de Carvalho Parahym AM; da Silva CM; Leão MP; Macario MC; Filho GA; de Oliveira NT; Neves RP
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):291-3. PubMed ID: 21924853
[TBL] [Abstract][Full Text] [Related]
16. An unusual case of Candida tropicalis and Candida krusei arthritis in a patient with acute myelogenous leukemia before chemotherapy.
Wang HP; Yen YF; Chen WS; Chou YL; Tsai CY; Chang HN; Chou CT
Clin Rheumatol; 2007 Jul; 26(7):1195-7. PubMed ID: 16767352
[TBL] [Abstract][Full Text] [Related]
17. No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
Bertz H; Drognitz K; Lübbert M
Ann Hematol; 2014 Jan; 93(1):165-7. PubMed ID: 23949313
[No Abstract] [Full Text] [Related]
18. Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies.
Girmenia C; Martino P; Cassone A
Blood; 1996 Jan; 87(2):838-9. PubMed ID: 8555510
[No Abstract] [Full Text] [Related]
19. Fluconazole-resistant Candida parapsilosis fungemia in a patient with AIDS.
Tumbarello M; Bevilacqua N; Federico G; Morace G; Cauda R; Tacconelli E
Clin Infect Dis; 1996 Jan; 22(1):179-80. PubMed ID: 8824996
[No Abstract] [Full Text] [Related]
20. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Jandourek A; Brown P; Vazquez JA
Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
